Results 231 to 240 of about 21,282,199 (350)

New Insights into the Pathophysiology of Type 2 Diabetes: A Review Article.

J Pharm Bioallied Sci
Vybhavi VSJ, Bhavsar M, Gusani J, Gohil Y, Paul NK, Garlapati HR, Shrivastava K.   +6 more
europepmc   +1 more source

Review Article: Individualised Management of Reflux-Like Symptoms-Strategies Beyond Acid Suppression. [PDF]

Aliment Pharmacol Ther
Kahrilas PJ, Keefer L, Yadlapati R, Anastasiou F, Heidelbaugh JJ, Howden CW, Mendive JM, Savarino EV, Udrescu M, Hungin APS.   +9 more
europepmc   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

Biomarkers for diagnosis and prognosis of myelin oligodendrocyte glycoprotein antibody-associated disease - review article. [PDF]

Front Immunol
Sapana T, Zhuo Z.
europepmc   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

Review article: Use of prehospital early warning scores to predict short-term mortality: A systematic review. [PDF]

Emerg Med Australas
Naylor D, Dicker B, Howie G, Todd V.
europepmc   +1 more source

Review of: "[Review Article] Excessive Aluminum in Soil" [PDF]

Guoyou Zhang
openalex   +1 more source

Annual review article: Is it time to rethink the gender agenda in entrepreneurship research?

, 2018
S. Marlow, Angela Martinez Dy
semanticscholar   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source